News
-
-
-
-
-
-
-
-
PRESS RELEASE
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Bausch Health to acquire DURECT, advancing innovative treatment for alcoholic hepatitis patients with larsucosterol, an epigenetic modulator. Transaction focuses on improving liver disease outcomes globally -
-